Mei Pharma Stock Market Value
| MEIP Stock | USD 2.70 0.10 3.57% |
| Symbol | MEI |
MEI Pharma Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEI Pharma. If investors know MEI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEI Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.99) | Revenue Per Share 9.8 | Quarterly Revenue Growth (1.00) | Return On Assets 0.2004 | Return On Equity 0.6168 |
The market value of MEI Pharma is measured differently than its book value, which is the value of MEI that is recorded on the company's balance sheet. Investors also form their own opinion of MEI Pharma's value that differs from its market value or its book value, called intrinsic value, which is MEI Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEI Pharma's market value can be influenced by many factors that don't directly affect MEI Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEI Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEI Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEI Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
MEI Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MEI Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MEI Pharma.
| 06/18/2024 |
| 12/15/2024 |
If you would invest 0.00 in MEI Pharma on June 18, 2024 and sell it all today you would earn a total of 0.00 from holding MEI Pharma or generate 0.0% return on investment in MEI Pharma over 180 days. MEI Pharma is related to or competes with Kezar Life, Vincerx Pharma, Avenue Therapeutics, Assembly Biosciences, Instil Bio, CytomX Therapeutics, and Achilles Therapeutics. MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various thera... More
MEI Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MEI Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MEI Pharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 16.76 | |||
| Value At Risk | (3.05) | |||
| Potential Upside | 2.96 |
MEI Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MEI Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MEI Pharma's standard deviation. In reality, there are many statistical measures that can use MEI Pharma historical prices to predict the future MEI Pharma's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.47) | |||
| Treynor Ratio | (0.29) |
MEI Pharma Backtested Returns
MEI Pharma has Sharpe Ratio of -0.0677, which conveys that the firm had a -0.0677% return per unit of volatility over the last 3 months. MEI Pharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify MEI Pharma's risk adjusted performance of (0.04), and Mean Deviation of 1.45 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.59, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, MEI Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding MEI Pharma is expected to be smaller as well. At this point, MEI Pharma has a negative expected return of -0.16%. Please make sure to verify MEI Pharma's value at risk, as well as the relationship between the daily balance of power and price action indicator , to decide if MEI Pharma performance from the past will be repeated in the future.
Auto-correlation | 0.18 |
Very weak predictability
MEI Pharma has very weak predictability. Overlapping area represents the amount of predictability between MEI Pharma time series from 18th of June 2024 to 16th of September 2024 and 16th of September 2024 to 15th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MEI Pharma price movement. The serial correlation of 0.18 indicates that over 18.0% of current MEI Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.18 | |
| Spearman Rank Test | 0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
MEI Pharma lagged returns against current returns
Autocorrelation, which is MEI Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting MEI Pharma's stock expected returns. We can calculate the autocorrelation of MEI Pharma returns to help us make a trade decision. For example, suppose you find that MEI Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
MEI Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If MEI Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if MEI Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in MEI Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
MEI Pharma Lagged Returns
When evaluating MEI Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of MEI Pharma stock have on its future price. MEI Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, MEI Pharma autocorrelation shows the relationship between MEI Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in MEI Pharma.
Regressed Prices |
| Timeline |
Pair Trading with MEI Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MEI Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MEI Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against MEI Stock
| 0.55 | FLGC | Flora Growth Corp | PairCorr |
| 0.37 | DYAI | Dyadic International | PairCorr |
| 0.35 | DNA | Ginkgo Bioworks Holdings | PairCorr |
| 0.32 | ESPR | Esperion Therapeutics | PairCorr |
| 0.32 | IMAB | I Mab | PairCorr |
The ability to find closely correlated positions to MEI Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MEI Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MEI Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MEI Pharma to buy it.
The correlation of MEI Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MEI Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MEI Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MEI Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for MEI Stock Analysis
When running MEI Pharma's price analysis, check to measure MEI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEI Pharma is operating at the current time. Most of MEI Pharma's value examination focuses on studying past and present price action to predict the probability of MEI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEI Pharma's price. Additionally, you may evaluate how the addition of MEI Pharma to your portfolios can decrease your overall portfolio volatility.